Integra Lifesciences Holdings (IART) Construction in Progress (2010 - 2013)
Integra Lifesciences Holdings (IART) reported Construction in Progress of $112.1 million for Q4 2013, up 24.25% on a YoY basis from $90.2 million in Q4 2012, and up 24.25% sequentially from $90.2 million in Q4 2012.
Integra Lifesciences Holdings (IART) Construction in Progress (2010 - 2013) Analysis & Trends
Integra Lifesciences Holdings (IART) has 4 years of Construction in Progress data on file, last reported at $112.1 million in Q4 2013.
- For the quarter ending Q4 2013, Construction in Progress rose 24.25% year-over-year to $112.1 million; the trailing twelve-month figure through Dec 2013 stood at $112.1 million (up 24.25% YoY), and the FY2013 full-year result was $112.1 million, up 24.25% from the prior year.
- Construction in Progress grew to $112.1 million in Q4 2013, from $90.2 million in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $112.1 million in Q4 2013 to a low of $20.1 million in Q4 2010.
- A 4-year average of $68.9 million and a median of $71.6 million in 2011 frame the typical range for Construction in Progress.
- Across the five-year window, Construction in Progress soared 163.02% in 2011 and climbed 24.25% in 2013, its largest moves.
- Tracing IART's Construction in Progress over 4 years: stood at $20.1 million in 2010, then soared by 163.02% to $53.0 million in 2011, then jumped by 70.38% to $90.2 million in 2012, then climbed by 24.25% to $112.1 million in 2013.
- Business Quant data shows IART's Construction in Progress at $112.1 million in Q4 2013, $90.2 million in Q4 2012, and $53.0 million in Q4 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integra Lifesciences Holdings | 1.71 Bn | 1.45 Bn | 216.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 112.13 Mn |
| Dec 31, 2012 | 90.24 Mn |
| Dec 31, 2011 | 52.97 Mn |
| Dec 31, 2010 | 20.14 Mn |